🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Through open-label, single-center, randomised clinical trials, we intend to...
Status
Unknown
Location
Multiple Locations
Start Date
2021-10-20
Trial ID
NCT05092217
Treatments Being Tested
Tislelizumab combined with chemotherapy sequential neoadjuvant therapy for ...
Status
Active Not Recruiting
Location
Sichuan Cancer Hospital and Research Institute
Start Date
2021-07-01
Trial ID
NCT05189730
Treatments Being Tested
To evaluate the efficacy and safety of low-dose decitabine combined with ti...
Status
Unknown
Location
Multiple Locations
Start Date
2023-01-01
Trial ID
NCT05638984
Treatments Being Tested
This is a Phase II, open-label study evaluating the efficacy and safety of ...
Status
Unknown
Location
Fudan University Shangshai Cancer Center
Start Date
2022-05-01
Trial ID
NCT05303038
Treatments Being Tested
To explore the efficiency and safety of Tislelizumab combinated with carbop...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2024-04-20
Trial ID
NCT06366945
Efficacy of Tirellizumab combined with TP neoadjuvant in the treatment of e...
Status
Active Not Recruiting
Location
Sun yat-sen memorial hospital
Start Date
2024-12-15
Trial ID
NCT07267286
This is a prospective, single-arm, single-center, exploratory clinical tria...
Status
Unknown
Location
Multiple Locations
Start Date
2023-08-01
Trial ID
NCT05965102
Treatments Being Tested
There are no standard chemotherapy regimens for relapse/refractory gray are...
Status
Unknown
Location
Multiple Locations
Start Date
2021-05-01
Trial ID
NCT04860674
Treatments Being Tested
The effective treatment of G/GEJ adenocarcinoma has always been a research ...
Status
Completed
Location
Xijing Hospital of Digestive Diseases
Start Date
2022-07-18
Trial ID
NCT05507658
Treatments Being Tested
To evaluate the efficacy and safety of vidicizumab combined with tirelizuma...
Status
Unknown
Location
WuhanHU
Start Date
2023-02-01
Trial ID
NCT05861635
Treatments Being Tested